Nurix Therapeutics Growth Metrics (2019-2025) | NRIX

Growth Metrics Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025
Growth Ratios
EBITDA Margin Growth (1y) -44513.0042,935.00-5106.00-5614.0018,697.00-21404.004,509.00-2739.00-15009.00-20467.0010,567.0031,264.0021,627.0041,877.006,595.00-31417.00-21717.00-18767.00-6802.0029,174.00-72382.00
EBITDA Margin Growth (3y) -40825.001,064.009,970.0022,911.0025,315.006.0021,671.00-2892.00-15099.002,643.0010,361.0029,020.00-72472.00
EBITDA Margin Growth (5y) -40915.0024,174.009,763.0020,667.00-68783.00
EBITDA Margin (QoQ) -70378.0029,016.0012,195.00-15346.0017,070.00-19025.0011,686.008,966.00-23031.006,888.004,439.00-3305.00-28489.0037,922.0025,135.00-12942.00-8239.002,641.00-12877.00-3241.00-5289.0014,606.0023,099.00-104797.00
EBIT Margin Growth (1y) -44513.0042,935.00-5106.00-5614.0018,697.00-21404.004,509.00-2739.00-15009.00-20467.0010,567.0031,264.0021,627.0041,877.006,595.00-31417.00-21717.00-18767.00-6802.0029,174.00-72382.00
EBIT Margin Growth (3y) -40825.001,064.009,970.0022,911.0025,315.006.0021,671.00-2892.00-15099.002,643.0010,361.0029,020.00-72472.00
EBIT Margin Growth (5y) -40915.0024,174.009,763.0020,667.00-68783.00
EBIT Margin (QoQ) -70378.0029,016.0012,195.00-15346.0017,070.00-19025.0011,686.008,966.00-23031.006,888.004,439.00-3305.00-28489.0037,922.0025,135.00-12942.00-8239.002,641.00-12877.00-3241.00-5289.0014,606.0023,099.00-104797.00
EBT Margin Growth (1y) -43045.0041,767.00-5075.00-5907.0017,083.00-21207.004,093.00-2705.00-14112.00-17957.0012,097.0031,800.0022,332.0041,196.007,132.00-28851.00-18800.00-16392.00-5558.0027,072.00-70651.00
EBT Margin Growth (3y) -40074.002,603.0011,115.0023,188.0025,303.002,033.0023,323.00244.00-10580.006,848.0013,671.0030,021.00-67118.00
EBT Margin Growth (5y) -36541.0027,408.0012,689.0021,409.00-64148.00
EBT Margin (QoQ) -69192.0028,251.0012,124.00-14227.0015,619.00-18592.0011,293.008,763.00-22671.006,708.004,495.00-2644.00-26515.0036,762.0024,197.00-12112.00-7651.002,698.00-11786.00-2061.00-5243.0013,531.0020,844.00-99784.00
Enterprise Value Growth (1y) 1,264.04%3,744.94%79.97%-27.99%-57.37%-81.64%-63.59%-77.60%-63.45%27.33%-61.86%-93.78%113.38%390.45%679.01%6,839.26%73.06%-66.74%-75.73%
Enterprise Value Growth (3y) 112.74%98.98%-37.01%-78.44%-30.73%4.66%2.66%-1.14%10.51%27.59%-10.32%
Enterprise Value Growth (5y) 89.85%93.83%-13.92%
Enterprise Value (QoQ) 27.25%127.80%-21.27%-21.35%27.60%-8.86%-53.39%-66.13%153.08%-43.93%-23.95%17.99%-24.19%-90.86%2,510.36%171.18%20.42%-18.60%-34.90%-47.88%-12.14%
FCF Margin Growth (1y) 41,607.00-127399.00-9061.00-11933.00-10985.00-62306.0016,190.00-15027.00-16778.007,927.0024,858.0022,476.0075,638.0012,958.00-28065.00-11765.00-54184.00-7959.0019,494.00-40759.00
FCF Margin Growth (3y) 13,845.00-181779.0031,987.00-4484.0047,876.00-41422.0012,983.00-4316.004,676.0012,925.0016,287.00-30048.00
FCF Margin Growth (5y) 35,299.00-176780.0023,416.00-57008.00
FCF Margin (QoQ) 215,370.00-180147.0019,238.00-12854.0046,363.00-61809.0016,366.00-11905.00-4958.0016,687.00-14850.00-13657.0019,746.0033,619.00-17233.0039,506.00-42934.00-7404.00-933.00-2913.003,291.0020,049.00-61185.00
Net Margin Growth (1y) -43035.0042,860.00-5179.00-55330.0017,203.00-21214.004,235.00-2509.00-14232.00-17915.0012,097.0031,800.0022,332.0041,196.007,078.00-28925.00-18865.00-16398.00-5504.0026,974.00-70586.00
Net Margin Growth (3y) -40064.003,731.0011,154.00-26039.0025,303.002,067.0023,410.00366.00-10765.006,884.0013,671.0029,848.00-67118.00
Net Margin Growth (5y) -36597.0028,530.0012,727.00-27991.00-64148.00
Net Margin (QoQ) -70311.0029,340.0061,390.00-63455.0015,585.00-18699.0011,239.009,079.00-22832.006,750.004,495.00-2644.00-26515.0036,762.0024,197.00-12112.00-7651.002,644.00-11806.00-2052.00-5184.0013,537.0020,672.00-99611.00
Operating Margin Growth (1y) -44513.0042,935.00-5106.00-5614.0018,697.00-21404.004,509.00-2739.00-15009.00-20467.0010,567.0031,264.0021,627.0041,877.006,595.00-31417.00-21717.00-18767.00-6802.0029,174.00-72382.00
Operating Margin Growth (3y) -40825.001,064.009,970.0022,911.0025,315.006.0021,671.00-2892.00-15099.002,643.0010,361.0029,020.00-72472.00
Operating Margin Growth (5y) -40915.0024,174.009,763.0020,667.00-68783.00
Operating Margin (QoQ) -70378.0029,016.0012,195.00-15346.0017,070.00-19025.0011,686.008,966.00-23031.006,888.004,439.00-3305.00-28489.0037,922.0025,135.00-12942.00-8239.002,641.00-12877.00-3241.00-5289.0014,606.0023,099.00-104797.00
Return on Assets Growth (1y) -13.00-16.00-18.00-20.00-17.00-16.00-7.00-5.00-2.002.004.0011.0011.0011.006.00-9.00
Return on Assets Growth (3y) -33.00-29.00-21.00-15.00-9.00-3.003.00-4.00
Return on Assets (QoQ) -3.00-6.000.00-5.00-5.00-8.00-3.00-1.00-4.002.00-1.002.000.003.006.002.000.00-2.00-10.00
Return on Capital Employed Growth (1y) -10.00-13.00-23.00-26.00-22.00-21.00-12.00-11.00-13.00-8.003.0014.0020.0022.0010.00-11.00
Return on Capital Employed Growth (3y) -45.00-42.00-32.00-23.00-15.00-7.002.00-8.00
Return on Capital Employed (QoQ) -4.000.000.00-6.00-7.00-10.00-3.00-2.00-6.00-1.00-2.00-4.00-1.0010.009.002.001.00-2.00-13.00
Return on Equity Growth (1y) -18.00-22.00-27.00-31.00-23.00-20.00-5.00-4.00-10.00-17.00-2.0013.0023.0037.0017.00-12.00
Return on Equity Growth (3y) -52.00-59.00-35.00-22.00-10.000.009.00-3.00
Return on Equity (QoQ) -5.00-7.001.00-7.00-9.00-12.00-2.000.00-6.003.00-1.00-6.00-12.0017.0014.005.001.00-3.00-15.00
Return on Invested Capital (QoQ) -5.00-1.00
Return on Sales Growth (1y) -283.00-59.00-151.00-118.00-10.00-94.00-73.00-34.00141.00220.00280.00249.00-6.00-97.00-168.00-190.0030.0021.00
Return on Sales Growth (3y) -152.0067.0056.0097.00125.0029.0039.0025.00165.00144.00
Return on Sales Growth (5y) -128.00-9.00
Return on Sales (QoQ) -177.0041.00-33.00-113.0047.00-52.000.00-5.00-38.00-30.0039.00170.0042.0030.008.00-86.00-49.00-41.00-15.00135.00-58.00